Pharma Journalist - Page 102 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Alora Pharmaceuticals Celebrates Acquisition of Monarch Manufacturing Facility

JanOne Inc. Completes Acquisition of Soin Therapeutics

Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology

Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

Nirsevimab US regulatory submission accepted for the prevention of RSV lower respiratory tract disease in infants and children up to age 24 months